SA518390920B1 - مركبات فينوكسي أسيتاميد معالجة بإضافة حلقة - Google Patents
مركبات فينوكسي أسيتاميد معالجة بإضافة حلقةInfo
- Publication number
- SA518390920B1 SA518390920B1 SA518390920A SA518390920A SA518390920B1 SA 518390920 B1 SA518390920 B1 SA 518390920B1 SA 518390920 A SA518390920 A SA 518390920A SA 518390920 A SA518390920 A SA 518390920A SA 518390920 B1 SA518390920 B1 SA 518390920B1
- Authority
- SA
- Saudi Arabia
- Prior art keywords
- phenoxyacetamides
- formula
- annelated
- novel
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
- C07C53/16—Halogenated acetic acids
- C07C53/18—Halogenated acetic acids containing fluorine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Abstract
يتعلق الاختراع الحالي بمركبات بالصيغة (I) حيث R1، R2، R3، وZ- لها أحد المعاني المشار إليها في الوصف أو ملح مقبول صيدلانياً منها، باستخدام مركبات بالصيغة (I) على هيئة دواء، بتركيبات صيدلانية pharmaceutical compositions تشتمل على مركب على الأقل بالصيغة (I)، بالإضافة إلى توليفات دوائية تحتوي على واحد أو أكثر من المركبات بالصيغة (I).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2015/069152 WO2017028927A1 (en) | 2015-08-20 | 2015-08-20 | Novel annelated phenoxyacetamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SA518390920B1 true SA518390920B1 (ar) | 2021-12-14 |
Family
ID=54065852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SA518390920A SA518390920B1 (ar) | 2015-08-20 | 2018-02-13 | مركبات فينوكسي أسيتاميد معالجة بإضافة حلقة |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP3298022B1 (ar) |
| JP (1) | JP6620171B2 (ar) |
| KR (1) | KR20180044333A (ar) |
| CN (1) | CN108200769B (ar) |
| AU (1) | AU2015406100B2 (ar) |
| BR (1) | BR112018001035A2 (ar) |
| CA (1) | CA2996087A1 (ar) |
| CO (1) | CO2018001700A2 (ar) |
| CY (1) | CY1122077T1 (ar) |
| DK (1) | DK3298022T3 (ar) |
| EA (1) | EA035738B1 (ar) |
| ES (1) | ES2739893T3 (ar) |
| HR (1) | HRP20191339T1 (ar) |
| HU (1) | HUE046014T2 (ar) |
| IL (1) | IL257136B (ar) |
| LT (1) | LT3298022T (ar) |
| ME (1) | ME03534B (ar) |
| MX (1) | MX370598B (ar) |
| MY (1) | MY194711A (ar) |
| PH (1) | PH12018500378B1 (ar) |
| PL (1) | PL3298022T3 (ar) |
| PT (1) | PT3298022T (ar) |
| RS (1) | RS59169B1 (ar) |
| SA (1) | SA518390920B1 (ar) |
| SI (1) | SI3298022T1 (ar) |
| UA (1) | UA121414C2 (ar) |
| WO (1) | WO2017028927A1 (ar) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201610854D0 (en) * | 2016-06-21 | 2016-08-03 | Entpr Therapeutics Ltd | Compounds |
| GB201619694D0 (en) | 2016-11-22 | 2017-01-04 | Entpr Therapeutics Ltd | Compounds |
| GB201717051D0 (en) | 2017-10-17 | 2017-11-29 | Enterprise Therapeutics Ltd | Compounds |
| GB201808093D0 (en) | 2018-05-18 | 2018-07-04 | Enterprise Therapeutics Ltd | Compounds |
| AU2021341508A1 (en) | 2020-09-10 | 2023-05-25 | Precirix N.V. | Antibody fragment against fap |
| WO2023203135A1 (en) | 2022-04-22 | 2023-10-26 | Precirix N.V. | Improved radiolabelled antibody |
| WO2023213801A1 (en) | 2022-05-02 | 2023-11-09 | Precirix N.V. | Pre-targeting |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011079087A1 (en) * | 2009-12-23 | 2011-06-30 | Glaxo Group Limited | Enac blockers |
| EP3022198B1 (en) * | 2013-07-15 | 2019-09-11 | Boehringer Ingelheim International GmbH | Novel 5-substituted benzimidazolium compounds |
| EP3022196B1 (en) * | 2013-07-15 | 2017-09-06 | Boehringer Ingelheim International GmbH | Novel benzimidazolium compounds |
| JP6461133B2 (ja) * | 2013-07-15 | 2019-01-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規４置換及び５置換ベンゾイミダゾリウム化合物 |
-
2015
- 2015-08-20 LT LTEP15760394.5T patent/LT3298022T/lt unknown
- 2015-08-20 AU AU2015406100A patent/AU2015406100B2/en not_active Ceased
- 2015-08-20 PT PT15760394T patent/PT3298022T/pt unknown
- 2015-08-20 MY MYPI2018000198A patent/MY194711A/en unknown
- 2015-08-20 DK DK15760394.5T patent/DK3298022T3/da active
- 2015-08-20 JP JP2017564088A patent/JP6620171B2/ja active Active
- 2015-08-20 SI SI201530828T patent/SI3298022T1/sl unknown
- 2015-08-20 RS RSP20191100 patent/RS59169B1/sr unknown
- 2015-08-20 ME MEP-2019-247A patent/ME03534B/me unknown
- 2015-08-20 UA UAA201802620A patent/UA121414C2/uk unknown
- 2015-08-20 PL PL15760394T patent/PL3298022T3/pl unknown
- 2015-08-20 MX MX2018001945A patent/MX370598B/es active IP Right Grant
- 2015-08-20 EA EA201890534A patent/EA035738B1/ru not_active IP Right Cessation
- 2015-08-20 BR BR112018001035-9A patent/BR112018001035A2/pt active Search and Examination
- 2015-08-20 HU HUE15760394A patent/HUE046014T2/hu unknown
- 2015-08-20 CA CA2996087A patent/CA2996087A1/en not_active Abandoned
- 2015-08-20 WO PCT/EP2015/069152 patent/WO2017028927A1/en active Application Filing
- 2015-08-20 ES ES15760394T patent/ES2739893T3/es active Active
- 2015-08-20 EP EP15760394.5A patent/EP3298022B1/en active Active
- 2015-08-20 CN CN201580083568.7A patent/CN108200769B/zh active Active
- 2015-08-20 KR KR1020187007950A patent/KR20180044333A/ko unknown
-
2018
- 2018-01-24 IL IL257136A patent/IL257136B/en unknown
- 2018-02-13 SA SA518390920A patent/SA518390920B1/ar unknown
- 2018-02-20 PH PH12018500378A patent/PH12018500378B1/en unknown
- 2018-02-20 CO CONC2018/0001700A patent/CO2018001700A2/es unknown
-
2019
- 2019-07-24 HR HRP20191339TT patent/HRP20191339T1/hr unknown
- 2019-09-05 CY CY20191100932T patent/CY1122077T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020551089A1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
| PH12018500591A1 (en) | Heterocyclic compounds and uses thereof | |
| PH12017500276A1 (en) | Aminopyrimidinyl compounds as jak inhibitors | |
| PH12018500377A1 (en) | Novel annelated benzamides | |
| SA518390920B1 (ar) | مركبات فينوكسي أسيتاميد معالجة بإضافة حلقة | |
| MX2018002402A (es) | Compuestos de heteroarilo o arilo biciclicos fusionados como moduladores de la quinasa 4 asociada al receptor de la interleucina 1 (irak4). | |
| PH12016500467B1 (en) | Aminoheteroarlyl benzamides as kinase inhibitors | |
| TW201613911A (en) | Heterocyclic compounds and uses thereof | |
| PH12018500061A1 (en) | Oxysterols and methods of use thereof | |
| TW201613864A (en) | Novel compounds | |
| PH12017501280B1 (en) | Hydroxyalkyl-piperazine derivatives as cxcr3 receptor modulators | |
| EA201790726A1 (ru) | Фармацевтическая композиция для лечения язвенного колита | |
| PH12015502632A1 (en) | Cxcr7 receptor modulators | |
| MX2017009292A (es) | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3. | |
| PH12018501709A1 (en) | Naphthridinedione derivatives | |
| MX368635B (es) | Compuestos tricíclicos de piperidina. | |
| MX2017002544A (es) | Derivados de isoquinolinona utiles en el tratamiento contra el cancer. | |
| WO2015181837A3 (en) | Novel compounds as anti-tubercular agents |